|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
ISO |
Nocodazole results in decreased expression of ABCC2 mRNA; Nocodazole results in decreased expression of ABCC2 protein |
CTD |
PMID:10691972 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO |
Nocodazole results in increased expression of ABCC3 mRNA |
CTD |
PMID:10691972 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression multiple interactions |
ISO |
Nocodazole results in increased expression of ACTA2 mRNA 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Nocodazole results in increased expression of ACTA2 mRNA] |
CTD |
PMID:31170432 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases activity |
ISO EXP |
Nocodazole results in decreased activity of AHR protein |
CTD |
PMID:16611024 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
multiple interactions |
ISO |
Nocodazole promotes the reaction [CCAR1 protein binds to ANAPC2 protein] |
CTD |
PMID:21903591 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases localization |
ISO |
Nocodazole inhibits the reaction [Dihydrotestosterone results in increased localization of AR protein] Nocodazole results in decreased localization of AR protein |
CTD |
PMID:20807808 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
Doxorubicin inhibits the reaction [Nocodazole inhibits the reaction [Hydroxyurea results in increased phosphorylation of ATM protein]]; Nocodazole inhibits the reaction [Hydroxyurea results in increased phosphorylation of ATM protein] |
CTD |
PMID:31597699 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp7b |
ATPase copper transporting beta |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [Copper affects the localization of ATP7B protein] |
CTD |
PMID:10982773 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Aurka |
aurora kinase A |
multiple interactions |
ISO |
[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Nocodazole] results in increased expression of and results in increased phosphorylation of AURKA protein; MLN8054 inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Nocodazole] results in increased phosphorylation of AURKA protein] |
CTD |
PMID:24976383 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
multiple interactions |
ISO |
4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Nocodazole] results in increased phosphorylation of AURKB protein]; [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Nocodazole] results in increased phosphorylation of AURKB protein |
CTD |
PMID:24976383 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Nocodazole analog results in increased expression of BAX protein |
CTD |
PMID:28412508 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases phosphorylation decreases expression multiple interactions |
ISO |
Nocodazole results in increased phosphorylation of BCL2 protein Nocodazole analog results in decreased expression of BCL2 protein TYMP inhibits the reaction [Nocodazole results in increased phosphorylation of BCL2 protein] |
CTD |
PMID:15907805 PMID:28412508 |
|
NCBI chr13:22,689,783...22,853,920
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
Nocodazole affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] |
CTD |
PMID:16373717 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
multiple interactions increases phosphorylation |
ISO |
[Nocodazole co-treated with Caffeine] results in increased expression of BUB1 protein modified form; chromium hexavalent ion inhibits the reaction [Nocodazole results in increased phosphorylation of BUB1 protein] |
CTD |
PMID:21670593 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
multiple interactions |
ISO |
[CAPZA1 protein co-treated with CAPZA2 protein] results in decreased susceptibility to Nocodazole |
CTD |
PMID:22918941 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Capza2 |
capping actin protein of muscle Z-line subunit alpha 2 |
multiple interactions |
ISO |
[CAPZA1 protein co-treated with CAPZA2 protein] results in decreased susceptibility to Nocodazole |
CTD |
PMID:22918941 |
|
NCBI chr 4:45,978,142...46,014,032
Ensembl chr 4:45,977,807...46,013,864
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions decreases expression |
ISO |
Nocodazole results in increased cleavage of CASP3 protein [Doxorubicin co-treated with Nocodazole co-treated with Hydroxyurea] results in increased cleavage of CASP3 protein; [Nocodazole co-treated with Hydroxyurea] results in increased cleavage of CASP3 protein; Caffeine promotes the reaction [[Doxorubicin co-treated with Nocodazole co-treated with Hydroxyurea] results in increased cleavage of CASP3 protein]; NOTCH1 protein mutant form inhibits the reaction [Caffeine promotes the reaction [[Doxorubicin co-treated with Nocodazole co-treated with Hydroxyurea] results in increased cleavage of CASP3 protein]] Nocodazole analog results in decreased expression of CASP3 protein |
CTD |
PMID:21903591 PMID:28412508 PMID:31597699 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage |
ISO |
Caspase Inhibitors inhibits the reaction [Nocodazole analog results in increased expression of CASP8 protein modified form] Nocodazole analog results in increased cleavage of CASP8 protein |
CTD |
PMID:28412508 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
Nocodazole analog results in increased cleavage of CASP9 protein |
CTD |
PMID:28412508 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
multiple interactions increases expression |
ISO |
Nocodazole inhibits the reaction [sodium arsenite affects the localization of CCAR1 protein]; Nocodazole promotes the reaction [CCAR1 protein binds to ANAPC2 protein] Nocodazole results in increased expression of CCAR1 protein |
CTD |
PMID:19073175 PMID:21903591 |
|
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Nocodazole results in increased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
Nocodazole analog results in increased expression of CCNB1 protein; Nocodazole results in increased expression of CCNB1 protein |
CTD |
PMID:21670593 PMID:28412508 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
ISO |
Nocodazole analog results in increased expression of CDK1 protein |
CTD |
PMID:28412508 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
multiple interactions |
ISO |
[Nocodazole co-treated with chromium hexavalent ion] results in decreased expression of and results in decreased phosphorylation of CDT1 protein |
CTD |
PMID:21670593 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cftr |
CF transmembrane conductance regulator |
affects localization multiple interactions |
ISO EXP |
Nocodazole affects the localization of CFTR protein Nocodazole inhibits the reaction [Cyclic AMP affects the localization of and results in increased activity of CFTR protein] |
CTD |
PMID:12529251 PMID:15994425 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
Nocodazole results in decreased expression of CHEK1 protein |
CTD |
PMID:26914363 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Nocodazole inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] |
CTD |
PMID:18346843 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO EXP |
Nocodazole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Nocodazole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Nocodazole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] Nocodazole inhibits the reaction [benzotriphenylene results in increased expression of and results in increased activity of CYP1A1 protein]; Nocodazole inhibits the reaction [benzotriphenylene results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:8190110 PMID:16611024 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [EGF protein results in increased expression of PSA mRNA] |
CTD |
PMID:20807808 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[TYMP co-treated with Nocodazole] results in decreased expression of FASLG mRNA; [TYMP co-treated with Nocodazole] results in decreased expression of FASLG protein |
CTD |
PMID:15907805 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxo5 |
F-box protein 5 |
multiple interactions |
ISO |
[Nocodazole co-treated with chromium hexavalent ion] results in decreased expression of FBXO5 protein |
CTD |
PMID:21670593 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
EXP |
Nocodazole results in increased expression of FIS1 protein |
CTD |
PMID:26732598 |
|
NCBI chr12:19,708,558...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Gmnn |
geminin, DNA replication inhibitor |
multiple interactions |
ISO |
[Nocodazole co-treated with chromium hexavalent ion] results in increased ubiquitination of GMNN protein |
CTD |
PMID:21670593 |
|
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Nocodazole results in increased expression of H2AX protein modified form |
CTD |
PMID:26914363 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression |
ISO |
Nocodazole results in decreased expression of HAMP mRNA |
CTD |
PMID:25633564 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Nocodazole results in increased expression of HSPA5 protein |
CTD |
PMID:26732598 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
ISO |
Nocodazole results in increased expression of IL6R protein modified form |
CTD |
PMID:20116850 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases phosphorylation multiple interactions |
ISO |
Nocodazole results in increased phosphorylation of JUN protein TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of JUN protein] |
CTD |
PMID:12221076 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
decreases response to substance |
ISO |
LCMT1 results in decreased susceptibility to Nocodazole |
CTD |
PMID:17724024 |
|
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:177,904,139...177,960,112
|
|
G |
Lzts1 |
leucine zipper tumor suppressor 1 |
affects response to substance |
ISO |
LZTS1 protein affects the susceptibility to Nocodazole |
CTD |
PMID:17349584 |
|
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein] Nocodazole inhibits the reaction [NGF protein results in increased activity of MAPK1 protein] |
CTD |
PMID:15907805 PMID:17822405 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein] Nocodazole inhibits the reaction [NGF protein results in increased activity of MAPK3 protein] |
CTD |
PMID:15907805 PMID:17822405 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
ISO |
TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:12221076 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation multiple interactions |
ISO |
Nocodazole results in increased phosphorylation of MAPK9 protein TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:12221076 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapt |
microtubule-associated protein tau |
decreases expression |
ISO |
Nocodazole results in decreased expression of MAPT protein |
CTD |
PMID:16930453 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Myt1 |
myelin transcription factor 1 |
increases phosphorylation |
ISO |
Nocodazole results in increased phosphorylation of MYT1 protein |
CTD |
PMID:16611024 |
|
NCBI chr 3:168,890,466...168,950,341
Ensembl chr 3:168,886,089...168,950,341
|
|
G |
Nanog |
Nanog homeobox |
decreases expression |
ISO |
Nocodazole results in decreased expression of NANOG protein |
CTD |
PMID:21559451 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
Nocodazole inhibits the reaction [NGF protein affects the localization of NTRK1 protein]; Nocodazole inhibits the reaction [NGF protein affects the localization of RAP1A protein]; Nocodazole inhibits the reaction [NGF protein results in increased activity of MAPK1 protein]; Nocodazole inhibits the reaction [NGF protein results in increased activity of MAPK3 protein]; Nocodazole inhibits the reaction [NGF protein results in increased activity of RAP1A protein] |
CTD |
PMID:17822405 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression multiple interactions |
ISO |
Nocodazole results in decreased expression of NOTCH1 protein BI 2536 inhibits the reaction [Nocodazole results in decreased expression of NOTCH1 protein]; Doxorubicin inhibits the reaction [Nocodazole promotes the reaction [Hydroxyurea results in decreased expression of NOTCH1 protein]]; Nocodazole promotes the reaction [Hydroxyurea results in decreased expression of NOTCH1 protein]; NOTCH1 protein mutant form inhibits the reaction [Caffeine promotes the reaction [[Doxorubicin co-treated with Nocodazole co-treated with Hydroxyurea] results in increased cleavage of CASP3 protein]] |
CTD |
PMID:31597699 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [NPC1 protein results in increased secretion of Daunorubicin] |
CTD |
PMID:16174794 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Npm1 |
nucleophosmin 1 |
affects phosphorylation |
ISO |
Nocodazole affects the phosphorylation of NPM1 protein |
CTD |
PMID:15190079 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
multiple interactions |
EXP |
Nocodazole inhibits the reaction [NGF protein affects the localization of NTRK1 protein] |
CTD |
PMID:17822405 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Optn |
optineurin |
affects localization |
ISO |
Nocodazole affects the localization of OPTN protein |
CTD |
PMID:25096716 |
|
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
TYMP inhibits the reaction [Nocodazole results in increased cleavage of PARP1 protein] Nocodazole analog results in increased cleavage of PARP1 protein; Nocodazole results in increased cleavage of PARP1 protein |
CTD |
PMID:15907805 PMID:21903591 PMID:28412508 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Plk1 |
polo-like kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
[Hydroxyurea co-treated with Nocodazole] affects the expression of and affects the phosphorylation of PLK1 protein; Doxorubicin affects the reaction [[Hydroxyurea co-treated with Nocodazole] affects the expression of and affects the phosphorylation of PLK1 protein] Nocodazole results in decreased phosphorylation of PLK1 protein |
CTD |
PMID:31597699 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
Nocodazole results in decreased expression of POU5F1 protein |
CTD |
PMID:21559451 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppp2r2a |
protein phosphatase 2, regulatory subunit B, alpha |
decreases response to substance |
ISO |
PPP2R2A results in decreased susceptibility to Nocodazole |
CTD |
PMID:17724024 |
|
NCBI chr15:41,204,659...41,263,924
Ensembl chr15:41,204,200...41,263,924
|
|
G |
Qrich1 |
glutamine-rich 1 |
multiple interactions increases phosphorylation |
ISO |
Genistein inhibits the reaction [Nocodazole results in increased phosphorylation of QRICH1 protein] |
CTD |
PMID:17510977 |
|
NCBI chr 8:109,216,900...109,256,472
Ensembl chr 8:109,217,376...109,261,359
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
multiple interactions |
ISO |
Nocodazole results in increased phosphorylation of [SUMO1 protein binds to RANGAP1 protein] |
CTD |
PMID:21646468 |
|
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions |
EXP |
Nocodazole inhibits the reaction [NGF protein affects the localization of RAP1A protein]; Nocodazole inhibits the reaction [NGF protein results in increased activity of RAP1A protein] |
CTD |
PMID:17822405 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of RELA protein] |
CTD |
PMID:29247640 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Sumo1 |
small ubiquitin-like modifier 1 |
multiple interactions |
ISO |
Nocodazole results in increased phosphorylation of [SUMO1 protein binds to RANGAP1 protein] |
CTD |
PMID:21646468 |
|
NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:61,077,435...61,108,761
|
|
G |
Tf |
transferrin |
decreases expression |
ISO |
Nocodazole results in decreased expression of TRF protein |
CTD |
PMID:34089742 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of JUN protein]; TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK8 protein]; TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK9 protein] Nocodazole analog results in increased expression of TP53 protein; Nocodazole results in increased expression of TP53 protein |
CTD |
PMID:12221076 PMID:21559451 PMID:28412508 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tuba1a |
tubulin, alpha 1A |
multiple interactions |
ISO |
Nocodazole inhibits the reaction [TUBA1A protein binds to TUBA1A protein] |
CTD |
PMID:19222062 |
|
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Tymp |
thymidine phosphorylase |
multiple interactions |
ISO |
[TYMP co-treated with Nocodazole] results in decreased expression of FASLG mRNA; [TYMP co-treated with Nocodazole] results in decreased expression of FASLG protein; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein]; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein]; TYMP inhibits the reaction [Nocodazole results in increased cleavage of PARP1 protein]; TYMP inhibits the reaction [Nocodazole results in increased phosphorylation of BCL2 protein] |
CTD |
PMID:15907805 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
Nocodazole results in increased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|